Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Bullboard Posts
Comment by Strathroy50on Feb 06, 2017 5:20pm
147 Views
Post# 25806910

RE:RE:RE:RE:RE:Kym Anthony selling

RE:RE:RE:RE:RE:Kym Anthony sellingCameron doesn't need to sell..as he continues to get paid every week whether there are sales or not. Whether he is the right person to take this company to the next level I don't know but they sure as heck are taking a very long time and IMO are getting closer each month to losing their ability to capitalize on their unique product. Eventually there will be others in this space it's just a matter of time. Their ability to prove and test their technology has been excellent (albeit time consuming) but their ability to close sales and generate revenue has been less than stellar. While the company's feedback of "things take time, people need to change" has some merit, I wonder whether a more experienced sales team and a more business skilled leader would have had them further along than where they are now. The potential with this company is so huge one can almost taste it, it's time Cameron to start making it happen in a concrete way that rewards shareholders.
Bullboard Posts